50 likes | 64 Views
Neurostimulation Devices Market to Reach a Valuation of ~US$ 15.3 Bn by 2027: Transparency Market Research<br>
E N D
©2019 Transparency Market Research, All Rights Reserved The Global Neurostimulation Devices Market to Reach a Valuation of ~US$ 15.3 Bn by 2027: Technological Advancements and New Product Development to Propel Market - TMR Neurostimulation Devices Market ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved Technological Advancements and New Product Development to Propel Market Rise in the demand for neurostimulation devices owing to unmet medical needs and demand for improved product outcomes and efficiency have led to the development of innovative products and technologies to address the unmet needs of patients as well as surgeons. In order to provide improved and alternative solutions to unmet medical needs in neurological disorders, companies have developed novel technologies and devices to improve the overall quality of life of affected patient population. For instance, in May 2019, Nevro Corp. launched the Senza Omnia Spinal Cord Stimulation (SCS) System in the U.S. Omnia is the first and the only spinal cord stimulation system designed to deliver its proprietary HF10 therapy along with all other available spinal cord stimulator frequencies. In January 2017, Abbott Laboratories launched the new Proclaim DRG neurostimulation system in Europe. The Proclaim DRG neurostimulation system is designed to deliver dorsal root ganglion (DRG) stimulation for patients suffering from chronic neuropathic pain. Abbott is the first and only company that offers DRG therapy and targeted relief for certain types of chronic pain.
©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Key Insights Chapter 6 Global Neurostimulation Devices Market Analysis and Forecast, by Product Global Neurostimulation Devices Market Analysis and Forecast, by Application Chapter 7 Chapter 8 Global Neurostimulation Devices Market Analysis and Forecast, by End-user Chapter 9 Global Neurostimulation Devices Market Analysis and Forecast, by Region Chapter 10 North America Neurostimulation Devices Market Analysis and Forecast
©2019 Transparency Market Research, All Rights Reserved AI and Machine Learning Steer Innovation in Smart Neuromodulation for Brain Damage Patients The trend of smart neuromodulation is engulfing the neurostimulation devices market. Better understanding of neural targets with AI is paving the way for technological advancements. Companies in the neurostimulation devices space are harnessing the techniques of machine learning to assess non-invasive brain computer interfaces. These techniques are creating opportunities catering to brain damage. scope for treatment Companies in the neurostimulation devices market are increasing research efforts in understanding brain functions and AI to overcome stagnation in neuromodulation technology. To sustain success in the landscape, healthcare industries will have to incorporate neurophilosophy of network science, since brain functions are complex and complicated. Neurophilosophy of network science is helping companies deploy novel stimulation designs such as burst stimulation. Request Sample of Report ©2019 Transparency Market Research, All Rights Reserved
©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U